Abstract
Osteoarthritis (OA) is the fastest growing cause of disability worldwide. The aim of this study was to understand the impact of OA on individuals and to explore current treatment strategies. An online UK-wide survey of people with self-reported OA was conducted, composed of 52 questions exploring the impact of OA, diagnosis and treatment, the role of health professionals and self-management. Four thousand forty-three people were invited with 2,001 respondents (49 % response, 56 % women; mean age 65 years). Fifty-two percent reported that OA had a large impact on their lives. Fifteen percent of respondents had taken early retirement on average 7.8 years earlier than planned. In consultations with general practitioners, only half reported a discussion on pain; fewer reported discussing their fears (21 %) or management goals (15 %). Nearly half (48 %) reported not seeking medical help until pain was frequently unbearable. Oral analgesics (62 %), topical therapies (47 %), physiotherapy (38 %) and steroid injections (28 %) were commonly used. The majority (71 %) reported varying degrees of persistent pain despite taking all prescribed medication. Although 64 % knew that increasing exercise was important, only 36 % acted on this knowledge; 87 % who increased exercise found it beneficial. Over half had future concerns related to mobility (60 %), maintaining independence (52 %) and coping with everyday activities (51 %). OA had significant individual economic impact especially on employment. Current treatment strategies still leave most people in pain with significant fears for the future. There is considerable opportunity to improve the holistic nature of OA consultations especially in provision of information and promotion of self-management strategies.
Similar content being viewed by others
References
Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M et al (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2163–2196
Hippisley-Cox J, Vinogradova TV (2009) Trends in consultation rates in general practice 1995/6 to 2008/9: Analysis of the QResearch database, NHS Information Centre for Health and Social Care. QResearch and the Health and Social Care Information Centre, Nottingham
Pereira D, Peleteiro B, Araujo J, Branco J, Santos RA, Ramos E (2011) The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthr Cartil 19(11):1270–1285
Briggs T (2012) Getting it right first time. Improving the quality of orthopaedic care within the National Health Service in England
Loza E, Abasolo L, Jover JA, Carmona L (2008) Burden of disease across chronic diseases: a health survey that measured prevalence, function, and quality of life. J Rheumatol 35(1):159–165
Cooper C, Arden NK (2011) Excess mortality in osteoarthritis. BMJ 342:d1407
Nuesch E, Dieppe P, Reichenbach S, Williams S, Iff S, Juni P (2011) All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ 342:d1165
Musculoskeletal Medicine (2009) Arthritis Research UK National Primary Care Centre, Keele University. Bulletin 1
A mandate from the Government to NHS England: April 2014 to March 2015. 12 November 2013. https://www.gov.uk/government/publications/nhs-mandate-2014-to-2015. Accessed 28 Mar 2014
Osteoarthritis. Care and management in adults (2014) NICE Clinical Guideline 177. February 2014. http://guidance.nice.org.uk/cg177
Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK et al (2010) OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoar Cartil 18(4):476–499
Kays K, Gathercoal K, Buhrow W (2012) Does survey format influence self-disclosure on sensitive question items? Comput Hum Behav 28(1):251–256
Royal College of General Practitioners’ Annual Prevalence Report (2007)
Hill S, Dziedzic KS, Ong BN (2010) The functional and psychological impact of hand osteoarthritis. Chron Illn 6(2):101–110
Jinks C, Ong BN, Richardson J (2007) A mixed methods study to investigate needs assessment for knee pain and disability: population and individual perspectives. BMC Musculoskelet Disord 8:59
Jinks C, Jordan K, Croft P (2007) Osteoarthritis as a public health problem: the impact of developing knee pain on physical function in adults living in the community: (KNEST 3). Rheumatology (Oxford) 46(5):877–881
Grotle M, Hagen KB, Natvig B, Dahl FA, Kvien TK (2008) Prevalence and burden of osteoarthritis: results from a population survey in Norway. J Rheumatol 35(4):677–684
Makela M, Heliovaara M, Sievers K, Knekt P, Maatela J, Aromaa A (1993) Musculoskeletal disorders as determinants of disability in Finns aged 30 years or more. J Clin Epidemiol 46(6):549–559
Bieleman HJ, Bierma-Zeinstra SM, Oosterveld FG, Reneman MF, Verhagen AP, Groothoff JW (2011) The effect of osteoarthritis of the hip or knee on work participation. J Rheumatol 38(9):1835–1843
Fautrel B, Hilliquin P, Rozenberg S, Allaert FA, Coste P, Leclerc A et al (2005) Impact of osteoarthritis: results of a nationwide survey of 10,000 patients consulting for OA. Joint Bone Spine 72(3):235–240
Gabriel SE, Crowson CS, Campion ME, O’Fallon WM (1997) Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls. J Rheumatol 24(1):43–48
Gignac MA, Cao X, Lacaille D, Anis AH, Badley EM (2008) Arthritis-related work transitions: a prospective analysis of reported productivity losses, work changes, and leaving the labor force. Arthritis Rheum 59(12):1805–1813
Loza E, Lopez-Gomez JM, Abasolo L, Maese J, Carmona L, Batlle-Gualda E (2009) Economic burden of knee and hip osteoarthritis in Spain. Arthritis Rheum 61(2):158–165
Jacobson L, Lindgren B (1996) What are the costs of illness? Socialstyrelsen (National Board of Health and Welfare), Stockholm
Leardini G, Salaffi F, Caporali R, Canesi B, Rovati L, Montanelli R (2004) Direct and indirect costs of osteoarthritis of the knee. Clin Exp Rheumatol 22(6):699–706
Rabenda V, Manette C, Lemmens R, Mariani AM, Struvay N, Reginster JY (2006) Direct and indirect costs attributable to osteoarthritis in active subjects. J Rheumatol 33(6):1152–1158
Le Pen C, Reygrobellet C, Gerentes I (2005) Financial cost of osteoarthritis in France. The “COART” France study. Joint Bone Spine 72(6):567–570
Jordan K, Clarke AM, Symmons DP, Fleming D, Porcheret M, Kadam UT et al (2007) Measuring disease prevalence: a comparison of musculoskeletal disease using four general practice consultation databases. Br J Gen Pract 57(534):7–14
Smith TO, Purdy R, Lister S, Salter C, Fleetcroft R, Conaghan PG (2014) Attitudes of people with osteoarthritis towards their conservative management: a systematic review and meta-ethnography. Rheumatol Int 34(3):299–313
Grime J, Richardson JC, Ong BN (2010) Perceptions of joint pain and feeling well in older people who reported being healthy: a qualitative study. Br J Gen Pract 60(577):597–603
Sanders C, Donovan JL, Dieppe PA (2004) Unmet need for joint replacement: a qualitative investigation of barriers to treatment among individuals with severe pain and disability of the hip and knee. Rheumatology (Oxford) 43(3):353–357
Dziedzic K, Thomas E, Hill S, Wilkie R, Peat G, Croft PR (2007) The impact of musculoskeletal hand problems in older adults: findings from the North Staffordshire Osteoarthritis Project (NorStOP). Rheumatology (Oxford) 46(6):963–967
Hill S, Dziedzic K, Thomas E, Baker SR, Croft P (2007) The illness perceptions associated with health and behavioural outcomes in people with musculoskeletal hand problems: findings from the North Staffordshire Osteoarthritis Project (NorStOP). Rheumatology (Oxford) 46(6):944–951
Bedson J, Mottram S, Thomas E, Peat G (2007) Knee pain and osteoarthritis in the general population: what influences patients to consult? Fam Pract 24(5):443–453
Kingsbury SR, Gross HJ, Isherwood G, Conaghan PG (2014) Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries. Rheumatology, Oxford
Kingsbury SR, Hensor EMA, Walsh CEA, Hochberg MC, Conaghan PG (2013) How do people with knee osteoarthritis use osteoarthritis pain medications and does this change over time? Data from the Osteoarthritis Initiative. Arthritis Res Ther 15(5):R106
Porcheret M, Jordan K, Jinks C, Croft P (2007) Primary care treatment of knee pain–a survey in older adults. Rheumatology (Oxford) 46(11):1694–1700
Mehrotra C, Naimi TS, Serdula M, Bolen J, Pearson K (2004) Arthritis, body mass index, and professional advice to lose weight: implications for clinical medicine and public health. Am J Prev Med 27(1):16–21
Keenan AM, Tennant A, Fear J, Emery P, Conaghan PG (2006) Impact of multiple joint problems on daily living tasks in people in the community over age fifty-five. Arthritis Rheum 55(5):757–764
Thomas E, Peat G, Croft P (2014) Defining and mapping the person with osteoarthritis for population studies and public health. Rheumatology (Oxford) 53(2):338–345
Conaghan PG, Dickson J, Grant RL (2008) Care and management of osteoarthritis in adults: summary of NICE guidance. BMJ 336(7642):502–503
Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J et al (2012) American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 64(4):455–474
Acknowledgments
The following companies have provided a sponsorship grant towards this independent programme to support OA Nation 2012: AstraZeneca, Napp Pharmaceuticals Limited, Pfizer Limited and Sanofi. These companies have also provided limited support and advice to Arthritis Care in relation to the collation of data for the project. However, editorial control of materials and decisions regarding OA Nation 2012 remain with Arthritis Care.
Disclosures
None.
Ethical approval
The study was conducted in line with the Market Research Society’s code of conduct. REC review was not required as participants were self-reporting and not identified through the NHS.
Funding
PGC and SRK are funded in part by Arthritis Research UK and the NIHR Leeds Musculoskeletal Biomedical Research Unit.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Conaghan, P.G., Porcheret, M., Kingsbury, S.R. et al. Impact and therapy of osteoarthritis: the Arthritis Care OA Nation 2012 survey. Clin Rheumatol 34, 1581–1588 (2015). https://doi.org/10.1007/s10067-014-2692-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-014-2692-1